Las Vegas, NV -- (SBWIRE) -- 12/13/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: WidePoint Corporation(NYSEMKT:WYY),Gevo, Inc. (NASDAQ:GEVO), RadioShack Corporation (NYSE:RSH), Hemispherx BioPharma, Inc (NYSEMKT:HEB)
WidePoint Corporation(NYSEMKT:WYY) managed to keep its gain at 5.84% on above-normal volume of 2.52M shares. The stock settled at $1.45 after floating in a range of $1.36 to $1.45. Its latest price has reached market capitalization of $92.59 billion. Its 52-week range has been $0.32 to $1.45. WidePoint Corporation provides technology-based products and solutions to government sector and commercial markets primarily in the United States. It operates in three segments: Communications Management, Cybersecurity Solutions, and Consulting Services and Products.
For How Long WYY will fight for Profitability? Read This Trend Analysis report
Gevo, Inc. (NASDAQ:GEVO) traded down on a volume of 2.43 million, higher than its standard daily volume. Shares have dropped-1.65% to $1.19. Over the last twelve months, the stock has lost/-15.6% and faced a worst price of $1.13. Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks.
Has GEVO Found The Bottom And Ready To Gain Momentum? Find Out Here
RadioShack Corporation (NYSE:RSH) settled -1.83% lower at $2.68 on above-normal volume of 2.35M shares during the last trading day. The stock has its 12-month high at $1.76 and 52-week low price was $2.05. It traded in a range of $2.66 to $2.74 during the last trading day. RadioShack Corporation engages in the retail sale of consumer electronics goods and services through its RadioShack store chain. The company operates in two segments, U.S. RadioShack company-operated stores and Target Mobile centers.
Will RSH Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Hemispherx BioPharma, Inc (NYSEMKT:HEB) was down on high volume, trading at a volume of 2.18M versus its average daily volume of 1.44 million shares. At $0.266, the stock has attained market capitalization of 4.60 million. Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome.
Why Should Investors Buy HEB After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)